Efficacy and Safety of Lenalidomide Combined With Azacitidine vs Azacitidine in the Treatment of MDS-RS
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE3
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AML
- Status
- RECRUITING
- Phase
- PHASE1
Study of BC3402 in Combination With Azacitidine in Patients With MDS and CMML
- Status
- RECRUITING
- Phase
- PHASE1
Clonal Hematopoiesis of Immunological Significance
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Expanded Access for Treatment With Imetelstat
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML
- Status
- TERMINATED
- Phase
- PHASE1
Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD
- Status
- RECRUITING
- Phase
- PHASE2
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
- Status
- RECRUITING
- Phase
- NA
Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- N/A
High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Telehealth Advance Care Planning Intervention
- Status
- RECRUITING
- Phase
- NA
A Study of Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE2
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1